Molecular imaging biomarker able to detect high-grade prostate cancer

A recent study has highlighted the ability of prostate-specific membrane antigen (PSMA) PET imaging to detect fast-growing primary prostate cancer and could prove significant in the care of patients with suspected prostate cancer that had not been confirmed by biopsy.

“We were able to demonstrate in our research that PSMA PET imaging was more specific than MR imaging for detection of clinically significant high-grade prostate cancer lesions, and importantly was able to distinguish benign prostate lesions from primary prostate cancer, currently a difficult diagnostic imaging task,” said co-author Steven P. Rowe, MD, PhD, resident at Johns Hopkins Medical Institutions in Baltimore. Read more.